Usage of brolucizumab as treatment for wet age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV): A narrative review. [PDF]
Jezani SN, Bastion MC.
europepmc +1 more source
Comparative efficacy of photodynamic therapy (PDT), ranibizumab, aflibercept monotherapy, and combination therapies for polypoidal choroidal vasculopathy: a network meta-analysis of randomized controlled trials. [PDF]
Quiroz-Reyes MA +3 more
europepmc +1 more source
Sozinibercept (Anti-VEGF-C/-D) Combined with Ranibizumab for Polypoidal Choroidal Vasculopathy: Phase IIb Predefined Subgroup Analysis. [PDF]
Cheung CMG +6 more
europepmc +1 more source
Polypoidal Choroidal Vasculopathy Complicated by Red Blood Cell-Coated Intraocular Lens: A Case Report. [PDF]
Sawazono A +4 more
europepmc +1 more source
Clinical characteristics and long-term treatment outcomes of polypoidal choroidal vasculopathy with classic type leakage. [PDF]
Kim JH, Park SM, Kim JW, Kim CG.
europepmc +1 more source
Unexpected retinal fluid compartment responses with anti-VEGF therapy in polypoidal choroidal vasculopathy: a case report of four patients. [PDF]
Gilead N +5 more
europepmc +1 more source
Slab-Specific Projection-Resolved Optical Coherence Tomography Angiography for Enhancing En Face Polyp Detection in Polypoidal Choroidal Vasculopathy. [PDF]
Wongchaisuwat N +6 more
europepmc +1 more source
Real world treatment outcomes in polypoidal choroidal vasculopathy in a Caucasian population of British ethnicity. [PDF]
De Salvo G +5 more
europepmc +1 more source
Development and validation of optical coherence tomography (OCT) and OCT angiography prediction model for short-term vitreous haemorrhage secondary to polypoidal choroidal vasculopathy. [PDF]
Cheng S, Zhao X, Zhao Q, Meng L, Chen Y.
europepmc +1 more source
Comparison of One-Year Outcome of Intravitreal Aflibercept with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy. [PDF]
Weng HY +8 more
europepmc +1 more source

